Press Releases on May 15, 2019 - EIN Presswire - Press Release Distribution Service

Published on May 15, 2019 - 21:07 GMT

MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast ...

Study meets first sequential primary endpoint of progression-free survival (PFS) in head-to-head with current standard of care (trastuzumab and chemotherapy) Oral abstract will be presented at American Society of Clinical Oncology (ASCO) Annual Meeting on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 15, 2019 - 21:06 GMT

Aduro Biotech to Host Investor Event Featuring ADU-S100 (MIW815) Clinical Data Presented at the 2019 American Society of Clinical ...

BERKELEY, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand ( …

Distribution channels: Conferences & Trade Fairs, Technology ...

Published on May 15, 2019 - 21:05 GMT

Aduro Biotech Announces Clinical Program Update for Anti-APRIL Antibody BION-1301

First healthy volunteer cohort cleared in Phase 1 first-in-human study of BION-1301 for the treatment of IgA nephropathy (IgAN); initial data in healthy volunteers expected in H1 2020 and IgAN patients in H2 2020 Results from the dose escalation portion …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on May 15, 2019 - 21:05 GMT

Lydian Announces First Quarter 2019 Results and Corporate Update

TORONTO, May 15, 2019 (GLOBE NEWSWIRE) -- Lydian International Limited (TSX:LYD) (“Lydian” or “the Company”) announced today its results for the three months ended March 31, 2019. All dollar amounts referenced in this news release are, unless otherwise …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry ...

Published on May 15, 2019 - 21:05 GMT

Atara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American ...

SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, …

Distribution channels: Technology ...

Published on May 15, 2019 - 21:04 GMT

TruStone Financial Provides Junior Achievement Programming to Elementary Students

PLYMOUTH, Minn., May 15, 2019 (GLOBE NEWSWIRE) -- TruStone Financial Federal Credit Union employees recently taught Junior Achievement classes to first grade students at Birchview Elementary in Plymouth, Minnesota. All costs associated with this JA …

Distribution channels: Banking, Finance & Investment Industry ...

Published on May 15, 2019 - 21:03 GMT

Micron Solutions, Inc. Reports 2019 First Quarter Results

FITCHBURG, Mich., May 15, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, Inc., producing highly-engineered, …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on May 15, 2019 - 21:03 GMT

TransCanna Executes LOI to Acquire Award-Winning Cannabis Brand SolDaze

VANCOUVER, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce today the execution of a non-binding Letter of Intent dated May 15, 2019 …

Distribution channels:

Published on May 15, 2019 - 21:03 GMT

Horizonte Minerals Quarterly Financial Statements for Three Months Ended 31 March 2019

LONDON, May 15, 2019 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc, (AIM: HZM, TSX: HZM) (‘Horizonte’ or ‘the Company’), the nickel development company focused in Brazil, announces it has today published its unaudited financial results for the three month …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry ...

Published on May 15, 2019 - 21:03 GMT

Chemung Financial Corporation Announces Quarterly Dividend

ELMIRA, N.Y., May 15, 2019 (GLOBE NEWSWIRE) -- Chemung Financial Corporation (Nasdaq: CHMG) announced today that its Board of Directors has approved a quarterly cash dividend of $0.26 per share, payable on July 1, 2019 to common stock shareholders of …

Distribution channels: Banking, Finance & Investment Industry ...

Published on May 15, 2019 - 21:01 GMT

Cybrexa Therapeutics’ Preclinical Data Demonstrate its alphalex™ Platform Enables Tumor Targeting of Multiple PARP Inhibitors, ...

Results support the potential of alphalex™ technology with diverse range of anticancer agents Targets HRD-negative cancers, while avoiding significant bone marrow toxicity typically induced when PARP inhibitors are combined with chemotherapy NEW HAVEN, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on May 15, 2019 - 21:01 GMT

Forty Seven, Inc. to Present Initial Safety and Efficacy Data from Phase 1b Clinical Trial of 5F9 in Patients with Acute Myeloid ...

-- Forty Seven to Host Investor Event and Webcast on June 3, 2019 -- -- Forty Seven Management to Participate in MATTER Panel, The Current and Future Wave of Immuno-Oncology Therapies, on May 30, 2019 -- MENLO PARK, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on May 15, 2019 - 21:01 GMT

Oncternal Therapeutics to Present Interim Data from a Phase 1/2 Study of Cirmtuzumab in Combination with Ibrutinib at the 2019 ...

SAN DIEGO, May 15, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., a clinical-stage biotechnology company focused on developing potential first-in-class therapeutic candidates for cancers with critical unmet medical need, today announced that it …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...